- Home
- RVMD
as 05-30-2025 4:00pm EST
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | REDWOOD CITY |
| Market Cap: | 7.4B | IPO Year: | 2020 |
| Target Price: | $68.67 | AVG Volume (30 days): | 2.0M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.02 | EPS Growth: | N/A |
| 52 Week Low/High: | $29.17 - $62.40 | Next Earning Date: | 05-07-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | 241.39% |
Latest Revolution Medicines Inc. News
RVMD Breaking Stock News: Dive into RVMD Ticker-Specific Updates for Smart Investing
Clinical Trials Arena
16 days ago
First subject dosed in Revolution Medicines’ Phase III NSCLC treatment trial
MT Newswires
17 days ago
Revolution Medicines Doses First Patient in Late-Stage Trial Evaluating Daraxonrasib to Treat Lung Cancer
GlobeNewswire
17 days ago
Revolution Medicines Announces First Patient Dosed in Phase 3 Clinical Trial Evaluating Daraxonrasib in Previously Treated Patients with RAS Mutant Non-Small Cell Lung Cancer
Simply Wall St.
21 days ago
We Think Revolution Medicines (NASDAQ:RVMD) Can Afford To Drive Business Growth
Thomson Reuters StreetEvents
23 days ago
Q1 2025 Revolution Medicines Inc Earnings Call
GuruFocus.com
23 days ago
Revolution Medicines Inc (RVMD) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ...
MT Newswires
23 days ago
Revolution Medicines Q1 Net Loss Widens
GlobeNewswire
23 days ago
Revolution Medicines Reports First Quarter 2025 Financial Results and Update on Corporate Progress
Compare RVMD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "RVMD Revolution Medicines Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.